Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols
Cancer · 2023
DOI: 10.1002/cncr.34823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2023. Verfasst von Catherine T Haring und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Papillomavirus Infections, Head and Neck Neoplasms, Oropharyngeal Neoplasms. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Development of evidence‐based post‐treatment surveillance guidelines in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) is limited by comprehensive documentation of patterns of recurrence and metastatic spread.
Methods
A retrospective analysis of patients diagnosed with R/M HNSCC at a National Cancer Institute‐designated cancer center between 1998– 2019 was performed ( n = 447). Univariate and multivariate analysis identified patterns of recurrence and predictors of survival.
Results
Median overall survival (mOS) improved over time (6.7 months in 1998–2007 to 11.8 months in 2008–2019, p = .006). Predictors of worse mOS included human papillomavirus (HPV) negativity (hazard ratio [HR], 1.8; 95% confidence interval [CI], 1.2–2.6), high neutrophil/lymphocyte ratio (HR, 2.1 [1.4–3.0], disease‐free interval (DFI) ≤6 months (HR, 1.4 [1.02–2.0]), and poor performance status (Eastern Cooperative Oncology Group, ≥2; HR, 1.91.1–3.4). In this cohort, 50.6% of recurrences occurred within 6 months of treatment completion, 72.5% occurred within 1 year, and 88.6% occurred within 2 years. Metachronous distant metastases were more likely to occur in patients with HPV‐positive disease (odds ratio [OR], 2.3 [1.4–4.0]), DFI >6 months (OR, 2.4 [1.5–4.0]), and body mass index ≥30 (OR, 2.3 [1.1–4.8]). Oligometastatic disease treated with local ablative therapy was associated with improved survival over polymetastatic disease (HR, 0.36; 95% CI, 0.24–0.55).
Conclusion
These data regarding patterns of distant metastasis in HNSCC support the clinical utility of early detection of recurrence. Patterns of recurrence in this population can be used to inform individualized surveillance programs as well as to risk‐stratify eligible patients for clinical trials. Plain Language Summary After treatment for head and neck cancer (HNC), patients are at risk of recurrence at prior sites of disease or at distant sites in the body. This study includes a large group of patients with recurrent or metastatic HNC and examines factors associated with survival outcomes and recurrence patterns. Patients with human papillomavirus (HPV)‐positive HNC have good survival outcomes, but if they recur, this may be in distant regions of the body and may occur later than HPV‐negative patients. These data argue for personalized follow‐up schedules for patients with HNC, perhaps incorporating imaging studies or novel blood tests.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Catherine T Haring, Sarah M Dermody, Steven B Chinn, Jennifer Shah, Paul L Swiecicki
Zitieren
APA
Haring, C. T., Kana, L. A., Dermody, S. M., Brummel, C., McHugh, J. B., Casper, K. A., Chinn, S. B., Malloy, K. M., Mierzwa, M., Prince, M. E. P., Rosko, A. J., Shah, J., Stucken, C. L., Shuman, A. G., Brenner, J. C., Spector, M. E., Worden, F. P., & Swiecicki, P. L. (2023). Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols. Cancer. https://doi.org/10.1002/cncr.34823
Vancouver
Haring CT, Kana LA, Dermody SM, Brummel C, McHugh JB, Casper KA, et al. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols. Cancer. 2023. doi:10.1002/cncr.34823
BibTeX
@article{Haring2023,
author = {Haring, Catherine T and Kana, Lulia A and Dermody, Sarah M and Brummel, Collin and McHugh, Jonathan B and Casper, Keith A and Chinn, Steven B and Malloy, Kelly M and Mierzwa, Michelle and Prince, Mark E P and Rosko, Andrew J and Shah, Jennifer and Stucken, Chaz L and Shuman, Andrew G and Brenner, J Chad and Spector, Matthew E and Worden, Francis P and Swiecicki, Paul L},
title = {Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols},
journal = {Cancer},
year = {2023},
doi = {10.1002/cncr.34823}
}
EUVIMED